--- title: "港股收评:恒生指数涨 0.57%,恒生科技指数跌 0.29%" description: "港股收盘,恒生指数涨 0.57%,恒生科技指数跌 0.29%。港股科技 ETF 收盘上涨 0.10%,恒生港股通 ETF 收盘上涨 0.61%。内房股领涨,绿地香港、佳兆业集团、融创中国均涨超 10%。老铺黄金跌超 5%。" type: "news" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/247943429.md" published_at: "2025-07-10T08:09:12.000Z" --- # 港股收评:恒生指数涨 0.57%,恒生科技指数跌 0.29% > 港股收盘,恒生指数涨 0.57%,恒生科技指数跌 0.29%。港股科技 ETF 收盘上涨 0.10%,恒生港股通 ETF 收盘上涨 0.61%。内房股领涨,绿地香港、佳兆业集团、融创中国均涨超 10%。老铺黄金跌超 5%。 港股收盘,恒生指数涨 0.57%,恒生科技指数跌 0.29%。港股科技 ETF 收盘上涨 0.10%,恒生港股通 ETF 收盘上涨 0.61%。内房股领涨,绿地香港、佳兆业集团、融创中国均涨超 10%。老铺黄金跌超 5%。 ### Related Stocks - [01918.HK - 融创中国](https://longbridge.com/zh-CN/quote/01918.HK.md) - [00HSI.HK - 恒生指数](https://longbridge.com/zh-CN/quote/00HSI.HK.md) - [01638.HK - 佳兆业集团](https://longbridge.com/zh-CN/quote/01638.HK.md) - [00337.HK - 绿地香港](https://longbridge.com/zh-CN/quote/00337.HK.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Hong Kong Securities Clearing Company Limited Ends CCASS Eligibility for Select Stocks | Hong Kong Securities Clearing Company Limited has announced the discontinuation of eligibility for certain stocks in the | [Link](https://longbridge.com/zh-CN/news/275696598.md) | | Sino Biopharmaceutical says NMPA approved Benmelstobart injection for marketing | Sino Biopharmaceutical says NMPA approved Benmelstobart injection for marketing | [Link](https://longbridge.com/zh-CN/news/276024005.md) | | Beijing Haizhi Technology Announces Final Offer Price | Beijing Haizhi Technology Group Co Ltd:FINAL OFFER PRICE HK$27.06 PER H SHARE UNDER GLOBAL OFFERING | [Link](https://longbridge.com/zh-CN/news/275780031.md) | | Shenhua Energy Gets Securities Regulator's Nod for Share Placement Plan | Shenhua Energy Gets Securities Regulator's Nod for Share Placement Plan | [Link](https://longbridge.com/zh-CN/news/275851575.md) | | Sino Biopharm Wins China Nod for New Lung Cancer Use of PD-L1 Drug | Sino Biopharmaceutical has received Chinese regulatory approval for its PD-L1 inhibitor, benmelstobart, for use as maint | [Link](https://longbridge.com/zh-CN/news/276016059.md) | --- > **免责声明**:本文内容仅供参考,不构成任何投资建议。